These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions. Cochran AJ, Binder S, Morton DL. J Cutan Pathol; 2010 Apr; 37 Suppl 1():54-9. PubMed ID: 20482676 [Abstract] [Full Text] [Related]
9. The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP). McArthur GJ, Banwell ME, Cook MG, Powell BW. J Plast Reconstr Aesthet Surg; 2007 Apr; 60(8):952-4. PubMed ID: 17616368 [Abstract] [Full Text] [Related]
10. Progress in melanoma histopathology and diagnosis. Piris A, Mihm MC. Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597 [Abstract] [Full Text] [Related]
11. [Malignant development of juvenile melanoma (Spitz's melanoma)]. Delacrétaz J. Dermatologica; 1969 Jun; 139(1):79-83. PubMed ID: 5810155 [No Abstract] [Full Text] [Related]
17. Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma. Kretschmer L, Hilgers R. J Clin Oncol; 2006 Jun 20; 24(18):2965-6; author reply 2966-7. PubMed ID: 16782937 [No Abstract] [Full Text] [Related]
18. Caution with sentinel node biopsy in cutaneous melanoma. Thomas JM. Br J Surg; 2006 Feb 20; 93(2):129-30. PubMed ID: 16432819 [No Abstract] [Full Text] [Related]